Tag:
Bayer Healthcare
Latest Headlines
Latest Headlines
Chinese court wants tougher clinical trial regs
India's struggles to regulate its booming clinical research industry are well told, but now China could be headed down the same path, as a Beijing court has taken issue with how trial-runners pay compensation to patients.
Bayer deepens Cambodian presence with DKSH partnership
DKSH, a pharma market-services contractor, has re-upped with Bayer Healthcare to help the drug giant expand its presence in Cambodia, agreeing to handle importation, regulatory clearance and distribution in the Asian nation.
Trial sites say Biogen, Forest, Bayer are top sponsors
According to CenterWatch's latest Global Investigative Site Relationship survey, clinical trial sites voted Biogen Idec, Forest Laboratories and Bayer the best sponsors, giving them the best marks on 36 relationship attributes.
Bayer spotlights positive PhIII data for fat-busting drug
Bayer Healthcare touted upbeat data from a pair of late-stage studies of an investigational drug targeting chin fat, setting the stage for the giant to step into growing aesthetic treatment market. And the results provide a victory from Kythera, which licensed the injected drug to Bayer for markets outside the U.S. and Canada.
FDA offers Bayer, Onyx fast review for regorafenib
Bayer HealthCare and Onyx Pharmaceuticals won an inside track at the FDA today for their closely-watched cancer drug regorafenib.
Covance, Bayer Healthcare enter strategic R&D partnership
The New Jersey CRO has teamed up with Bayer Healthcare in a deal that will see the two helping one another with R&D services.
Bayer details positive PhIII data on cancer blockbuster hopeful regorafenib
Bayer HealthCare took another step toward a planned marketing application for the cancer drug regorafenib today as it unveiled the late-stage colorectal cancer data that it plans to take to
Ventana, Bayer to collaborate on companion Dx for cancer
Another week, another big personalized medicine partnership announcement from Ventana Medical Systems . This time, the Roche unit said it will be working with Bayer Pharma on a molecular companion
Onyx Pharma shares soar on report of its hunt for options, acquirers
A report about Onyx Pharmaceuticals' ( $ONXX ) search for business alternatives such as a company sale has generated buzz in the biotech world. Bloomberg reported Monday afternoon that the South San
FDA pins approval on Regeneron eye drug Eylea
Regeneron ( $REGN ) is wrapping up the week with a big victory. U.S. regulators have given market approval to the Tarrytown, NY-based company's Eylea for treating a neurovascular form of wet
